A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Ranging Study to Evaluate IDP-107 Versus Placebo in the Treatment of Severe Acne Vulgaris With Nodules
A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Ranging Study to Evaluate IDP-107 Versus Placebo in the Treatment of Severe Acne Vulgaris With Nodules
The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.
Inclusion Criteria:
Exclusion Criteria:
Fort Gratiot, Michigan 48059, United States
Chapel Hill, North Carolina 27599, United States